Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Sutter

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|September 9, 1993
Vaccine-associated paralytic poliomyelitisL Mermel, D Sanchez de Mora, R W Sutter, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|December 8, 2004
Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP)D R Prevots, R K Burr, R W Sutter, et al.
Infectious Disease Clinics of North America|April 17, 2001
Poliomyelitis eradication: progress, challenges for the end game, and preparation for the post-eradication eraR W Sutter, R H Tangermann, R B Aylward, et al.
American Journal of Epidemiology|January 1, 1990
Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984R W Sutter, S L Cochi, E W Brink, et al.
JAMA|September 25, 1996
Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization scheduleM A Miller, R W Sutter, P M Strebel, et al.
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries|December 11, 1992
Tetanus surveillance--United States, 1989-1990R Prevots, R W Sutter, P M Strebel, et al.
Annals of the New York Academy of Sciences|May 31, 1995
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccinationR W Sutter, M A Pallansch, L A Sawyer, et al.
Journal of General Internal Medicine|February 1, 1994
Tetanus immunization: concerns about the elderly and about diphtheria reemergenceR W Sutter, R A Strikas, S C Hadler, et al.
Archives of Pediatrics & Adolescent Medicine|May 1, 1994
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated diseaseD R Prevots, R W Sutter, P M Strebel, et al.
The New England Journal of Medicine|February 23, 1995
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitisP M Strebel, N Ion-Nedelcu, A L Baughman, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|September 9, 1993
Vaccine-associated paralytic poliomyelitisL Mermel, D Sanchez de Mora, R W Sutter, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|December 8, 2004
Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP)D R Prevots, R K Burr, R W Sutter, et al.
Infectious Disease Clinics of North America|April 17, 2001
Poliomyelitis eradication: progress, challenges for the end game, and preparation for the post-eradication eraR W Sutter, R H Tangermann, R B Aylward, et al.
American Journal of Epidemiology|January 1, 1990
Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984R W Sutter, S L Cochi, E W Brink, et al.
JAMA|September 25, 1996
Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization scheduleM A Miller, R W Sutter, P M Strebel, et al.
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries|December 11, 1992
Tetanus surveillance--United States, 1989-1990R Prevots, R W Sutter, P M Strebel, et al.
Annals of the New York Academy of Sciences|May 31, 1995
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccinationR W Sutter, M A Pallansch, L A Sawyer, et al.
Journal of General Internal Medicine|February 1, 1994
Tetanus immunization: concerns about the elderly and about diphtheria reemergenceR W Sutter, R A Strikas, S C Hadler, et al.
Archives of Pediatrics & Adolescent Medicine|May 1, 1994
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated diseaseD R Prevots, R W Sutter, P M Strebel, et al.
The New England Journal of Medicine|February 23, 1995
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitisP M Strebel, N Ion-Nedelcu, A L Baughman, et al.
Pageof 7